Regulatory Recap: BRICS Countries Discuss Building Independent Market For Biosimilars

Also, Regulatory Updates From The FDA, IGBA, And The Philippines

Generics Bulletin recaps the most recent regulatory news from across the world.

BRICS countries puzzle
• Source: Shutterstock

More from Regulation

More from Policy & Regulation